A woman, aged 61, had a colonoscopy because of a positive result from a fecal occult blood test. No abnormalities were detected in the colon but endoscopic examination of the terminal ileum showed ...
Background and Aim: Since the diagnostic value of ileoscopy is not well documented, it is uncertain if terminal ileum intubation should be performed routinely in patients undergoing colonoscopy. We ...
THE fact that extension of the inflammatory process to the terminal portion of the ileum occurs in patients with chronic ulcerative colitis is fairly well known, but it has not received sufficient ...
The cutaneous catheterizable ileocecocytoplasty is a surgery that we have found to be very successful here at University of Utah Health. In this surgery the bladder is expanded with large bowel from ...
Intestinal bile acid absorption in the rat primarily takes place in the terminal ileum. At least two specific proteins appear to mediate this process; one of these is ASBT, which facilitates uptake of ...
IT IS the purpose of this paper to report and discuss a patient with cicatrizing ileitis, accompanied by obstruction and abscess, who was observed during the seventh month of pregnancy. Surgical ...
Carlsbad, CA, May 27, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and ...
Necrotizing enterocolitis (NEC) afflicts extremely low birth weight neonates, and probiotics reduces its incidence and severity. NO is involved in the pathogenesis of NEC, and caveolin-1 regulates NO ...
Palisade Bio, Inc. (Palisade), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic ...
No serious adverse events (SAEs) or treatment-emergent adverse events (TEAEs) related to laboratory values or EKGs observed across SAD/MAD cohorts Management releases a “What This Means” segment ...
Carlsbad, CA, May 27, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade”, "Palisade Bio”, or the "Company”), a clinical-stage biopharmaceutical company focused on developing and ...
Study met its primary endpoints of safety, tolerability, and pharmacokinetics (PK) No serious adverse events (SAEs) or treatment-emergent adverse events (TEAEs) related to laboratory values or EKGs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results